Antiphospholipid Syndrome (APS), also known as Hughes syndrome is an autoimmune disease defined by the development of venous and/or arterial thrombosis, often multiple, and pregnancy morbidity.
Endotelix offers fast, reliable and specific solutions for clinical APS management, including diagnostic tools and treatments.
Endotelix is fully focused on innovation within the field of antiphospholipid syndrome. As such, our pipeline is centred on two main clinical developmental projects:
Diagnostics and Treatments